RSV Diagnostics Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product (Kits and Assays, Instruments); Method (Rapid Antigen Detection Test, Molecular Diagnostic); End User (Hospitals and Clinics, Clinical Laboratories, Homecare settings); and Geography

Report Code: TIPRE00020237 | No. of Pages: 150 | Category: Medical Device | Status: Upcoming

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!
MARKET INTRODUCTION

Respiratory Syncytial Virus (RSV) is a single-stranded RNA virus respiratory pathogen causing lower respiratory tract infections such as pneumonia, bronchiolitis, and other related diseases, prominently among the elderly, and infants. It comprises a considerable disease burden across the globe due to high infection rate. RSV infection is more prominent during the rainy season in tropical season. Lately, cases related to RSV are on the rise. To limit the spread of RSV, early detection is necessary.

MARKET DYNAMICS

Factors such as growing demand in point of care testing diagnostic test for RSV infected person and the development in field of specific markers such as proteomics and genomic will spur the demand for RSV diagnostics market. Additionally, rising neonatal population base, and increasing demand for in-vitro diagnostics will boost the market growth to significant extent over the forecast period. However, low detection of immunoassays and growing developments in RSV vaccines impede the growth of the market in the forecasted period.

MARKET SCOPE

The "Global RSV diagnostics Market Analysis to 2028" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of RSV diagnostics market with detailed market segmentation by on type, method, end-user and geography. The global RSV diagnostics market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading RSV diagnostics market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The global RSV diagnostics market is segmented on product, method and end-user. Based on type, the global RSV diagnostics market is segmented into kits and assays, instruments. Based on method, the global RSV diagnostics market is segmented into rapid antigen detection test, and molecular diagnostic. Based on end user, the global RSV diagnostics market is segmented into hospitals & clinics, clinical laboratories, homecare.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global RSV diagnostics market based on various segments. It also provides market size and forecast estimates from year 2019 to 2028 with respect to five major regions, namely, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The RSV diagnostics market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting RSV diagnostics market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely, North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the RSV diagnostics market in these regions.



Get more information on this report :

MARKET PLAYERS


The reports cover key developments in the RSV diagnostics market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from RSV diagnostics market are anticipated to lucrative growth opportunities in the future with the rising demand for RSV diagnostics market in the global market. Below mentioned is the list of few companies engaged in the RSV diagnostics market.

The report also includes the profiles of key RSV diagnostics market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •   bioMérieux SA
  •   Abbott
  •   F. Hoffmann-La Roche Ltd
  •   BD
  •   Thermo Fisher Scientific
  •   Luminex Corporation
  •   Danaher Corporation
  •   Biocartis SA
  •   Hologic, Inc
  •   Alnylam Pharmaceuticals, Inc.

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 RSV Diagnostics Market - By Product
1.3.2 RSV Diagnostics Market - By Method
1.3.3 RSV Diagnostics Market - By End User
1.3.4 RSV Diagnostics Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. RSV DIAGNOSTICS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. RSV DIAGNOSTICS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. RSV DIAGNOSTICS MARKET - GLOBAL MARKET ANALYSIS
6.1. RSV DIAGNOSTICS - GLOBAL MARKET OVERVIEW
6.2. RSV DIAGNOSTICS - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. RSV DIAGNOSTICS MARKET - REVENUE AND FORECASTS TO 2028 - PRODUCT
7.1. OVERVIEW
7.2. PRODUCT MARKET FORECASTS AND ANALYSIS
7.3. KITS AND ASSAYS
7.3.1. Overview
7.3.2. Kits and Assays Market Forecast and Analysis
7.4. INSTRUMENTS
7.4.1. Overview
7.4.2. Instruments Market Forecast and Analysis
8. RSV DIAGNOSTICS MARKET - REVENUE AND FORECASTS TO 2028 - METHOD
8.1. OVERVIEW
8.2. METHOD MARKET FORECASTS AND ANALYSIS
8.3. RAPID ANTIGEN DETECTION TEST
8.3.1. Overview
8.3.2. Rapid Antigen Detection Test Market Forecast and Analysis
8.3.3. Immunofluorescence Assay Market
8.3.3.1. Overview
8.3.3.2. Immunofluorescence Assay Market Forecast and Analysis
8.3.4. ELISA Market
8.3.4.1. Overview
8.3.4.2. ELISA Market Forecast and Analysis
8.4. MOLECULAR DIAGNOSTIC
8.4.1. Overview
8.4.2. Molecular Diagnostic Market Forecast and Analysis
9. RSV DIAGNOSTICS MARKET - REVENUE AND FORECASTS TO 2028 - END USER
9.1. OVERVIEW
9.2. END USER MARKET FORECASTS AND ANALYSIS
9.3. HOSPITALS AND CLINICS
9.3.1. Overview
9.3.2. Hospitals and Clinics Market Forecast and Analysis
9.4. CLINICAL LABORATORIES
9.4.1. Overview
9.4.2. Clinical Laboratories Market Forecast and Analysis
9.5. HOMECARE SETTINGS
9.5.1. Overview
9.5.2. Homecare settings Market Forecast and Analysis
10. RSV DIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America RSV Diagnostics Market Overview
10.1.2 North America RSV Diagnostics Market Forecasts and Analysis
10.1.3 North America RSV Diagnostics Market Forecasts and Analysis - By Product
10.1.4 North America RSV Diagnostics Market Forecasts and Analysis - By Method
10.1.5 North America RSV Diagnostics Market Forecasts and Analysis - By End User
10.1.6 North America RSV Diagnostics Market Forecasts and Analysis - By Countries
10.1.6.1 United States RSV Diagnostics Market
10.1.6.1.1 United States RSV Diagnostics Market by Product
10.1.6.1.2 United States RSV Diagnostics Market by Method
10.1.6.1.3 United States RSV Diagnostics Market by End User
10.1.6.2 Canada RSV Diagnostics Market
10.1.6.2.1 Canada RSV Diagnostics Market by Product
10.1.6.2.2 Canada RSV Diagnostics Market by Method
10.1.6.2.3 Canada RSV Diagnostics Market by End User
10.1.6.3 Mexico RSV Diagnostics Market
10.1.6.3.1 Mexico RSV Diagnostics Market by Product
10.1.6.3.2 Mexico RSV Diagnostics Market by Method
10.1.6.3.3 Mexico RSV Diagnostics Market by End User
10.2. EUROPE
10.2.1 Europe RSV Diagnostics Market Overview
10.2.2 Europe RSV Diagnostics Market Forecasts and Analysis
10.2.3 Europe RSV Diagnostics Market Forecasts and Analysis - By Product
10.2.4 Europe RSV Diagnostics Market Forecasts and Analysis - By Method
10.2.5 Europe RSV Diagnostics Market Forecasts and Analysis - By End User
10.2.6 Europe RSV Diagnostics Market Forecasts and Analysis - By Countries
10.2.6.1 Germany RSV Diagnostics Market
10.2.6.1.1 Germany RSV Diagnostics Market by Product
10.2.6.1.2 Germany RSV Diagnostics Market by Method
10.2.6.1.3 Germany RSV Diagnostics Market by End User
10.2.6.2 France RSV Diagnostics Market
10.2.6.2.1 France RSV Diagnostics Market by Product
10.2.6.2.2 France RSV Diagnostics Market by Method
10.2.6.2.3 France RSV Diagnostics Market by End User
10.2.6.3 Italy RSV Diagnostics Market
10.2.6.3.1 Italy RSV Diagnostics Market by Product
10.2.6.3.2 Italy RSV Diagnostics Market by Method
10.2.6.3.3 Italy RSV Diagnostics Market by End User
10.2.6.4 Spain RSV Diagnostics Market
10.2.6.4.1 Spain RSV Diagnostics Market by Product
10.2.6.4.2 Spain RSV Diagnostics Market by Method
10.2.6.4.3 Spain RSV Diagnostics Market by End User
10.2.6.5 United Kingdom RSV Diagnostics Market
10.2.6.5.1 United Kingdom RSV Diagnostics Market by Product
10.2.6.5.2 United Kingdom RSV Diagnostics Market by Method
10.2.6.5.3 United Kingdom RSV Diagnostics Market by End User
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific RSV Diagnostics Market Overview
10.3.2 Asia-Pacific RSV Diagnostics Market Forecasts and Analysis
10.3.3 Asia-Pacific RSV Diagnostics Market Forecasts and Analysis - By Product
10.3.4 Asia-Pacific RSV Diagnostics Market Forecasts and Analysis - By Method
10.3.5 Asia-Pacific RSV Diagnostics Market Forecasts and Analysis - By End User
10.3.6 Asia-Pacific RSV Diagnostics Market Forecasts and Analysis - By Countries
10.3.6.1 Australia RSV Diagnostics Market
10.3.6.1.1 Australia RSV Diagnostics Market by Product
10.3.6.1.2 Australia RSV Diagnostics Market by Method
10.3.6.1.3 Australia RSV Diagnostics Market by End User
10.3.6.2 China RSV Diagnostics Market
10.3.6.2.1 China RSV Diagnostics Market by Product
10.3.6.2.2 China RSV Diagnostics Market by Method
10.3.6.2.3 China RSV Diagnostics Market by End User
10.3.6.3 India RSV Diagnostics Market
10.3.6.3.1 India RSV Diagnostics Market by Product
10.3.6.3.2 India RSV Diagnostics Market by Method
10.3.6.3.3 India RSV Diagnostics Market by End User
10.3.6.4 Japan RSV Diagnostics Market
10.3.6.4.1 Japan RSV Diagnostics Market by Product
10.3.6.4.2 Japan RSV Diagnostics Market by Method
10.3.6.4.3 Japan RSV Diagnostics Market by End User
10.3.6.5 South Korea RSV Diagnostics Market
10.3.6.5.1 South Korea RSV Diagnostics Market by Product
10.3.6.5.2 South Korea RSV Diagnostics Market by Method
10.3.6.5.3 South Korea RSV Diagnostics Market by End User
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa RSV Diagnostics Market Overview
10.4.2 Middle East and Africa RSV Diagnostics Market Forecasts and Analysis
10.4.3 Middle East and Africa RSV Diagnostics Market Forecasts and Analysis - By Product
10.4.4 Middle East and Africa RSV Diagnostics Market Forecasts and Analysis - By Method
10.4.5 Middle East and Africa RSV Diagnostics Market Forecasts and Analysis - By End User
10.4.6 Middle East and Africa RSV Diagnostics Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa RSV Diagnostics Market
10.4.6.1.1 South Africa RSV Diagnostics Market by Product
10.4.6.1.2 South Africa RSV Diagnostics Market by Method
10.4.6.1.3 South Africa RSV Diagnostics Market by End User
10.4.6.2 Saudi Arabia RSV Diagnostics Market
10.4.6.2.1 Saudi Arabia RSV Diagnostics Market by Product
10.4.6.2.2 Saudi Arabia RSV Diagnostics Market by Method
10.4.6.2.3 Saudi Arabia RSV Diagnostics Market by End User
10.4.6.3 U.A.E RSV Diagnostics Market
10.4.6.3.1 U.A.E RSV Diagnostics Market by Product
10.4.6.3.2 U.A.E RSV Diagnostics Market by Method
10.4.6.3.3 U.A.E RSV Diagnostics Market by End User
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America RSV Diagnostics Market Overview
10.5.2 South and Central America RSV Diagnostics Market Forecasts and Analysis
10.5.3 South and Central America RSV Diagnostics Market Forecasts and Analysis - By Product
10.5.4 South and Central America RSV Diagnostics Market Forecasts and Analysis - By Method
10.5.5 South and Central America RSV Diagnostics Market Forecasts and Analysis - By End User
10.5.6 South and Central America RSV Diagnostics Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil RSV Diagnostics Market
10.5.6.1.1 Brazil RSV Diagnostics Market by Product
10.5.6.1.2 Brazil RSV Diagnostics Market by Method
10.5.6.1.3 Brazil RSV Diagnostics Market by End User
10.5.6.2 Argentina RSV Diagnostics Market
10.5.6.2.1 Argentina RSV Diagnostics Market by Product
10.5.6.2.2 Argentina RSV Diagnostics Market by Method
10.5.6.2.3 Argentina RSV Diagnostics Market by End User
11. IMPACT OF COVID-19 PANDEMIC ON GLOBAL RSV DIAGNOSTICS MARKET
11.1 North America
11.2 Europe
11.3 Asia-Pacific
11.4 Middle East and Africa
11.5 South and Central America
12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. RSV DIAGNOSTICS MARKET, KEY COMPANY PROFILES
13.1. BIOMéRIEUX SA
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. ABBOTT
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. F. HOFFMANN-LA ROCHE LTD
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. BD
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. THERMO FISHER SCIENTIFIC
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. LUMINEX CORPORATION
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. DANAHER CORPORATION
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. BIOCARTIS SA
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. HOLOGIC, INC
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. ALNYLAM PHARMACEUTICALS, INC.
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
The List of Companies

1. bioMérieux SA
2. Abbott
3. F. Hoffmann-La Roche Ltd
4. BD
5. Thermo Fisher Scientific
6. Luminex Corporation
7. Danaher Corporation
8. Biocartis SA
9. Hologic, Inc
10. Alnylam Pharmaceuticals, Inc.
TIPRE00020237
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking